This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Bernardis, F.
Right arrow Articles by Cassone, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Bernardis, F.
Right arrow Articles by Cassone, A.

 Previous Article  |  Next Article 

Infect. Immun., Feb 1996, 466-471, Vol 64, No. 2
Copyright © 1996, American Society for Microbiology

Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus

F De Bernardis, P Chiani, M Ciccozzi, G Pellegrini, T Ceddia, G D'Offizzi, I Quinti, PA Sullivan and A Cassone
Department of Bacteriology and Medical Mycology, Istituto Superiore di Sanita, Rome, Italy.

Isolates of Candida albicans from the oral cavities of subjects at different stages of human immunodeficiency virus (HIV) infection or uninfected controls were examined for (i) production of aspartic proteinase(s), a putative virulence-associated factor(s); (ii) the presence in the fungal genome of two major genes (SAP1 and SAP2) of the aspartic proteinase family; and (iii) experimental pathogenicity in a murine model of systemic infection. It was found that the fungal isolates from symptomatic patients secreted, on average, up to eightfold more proteinase than the isolates from uninfected or HIV- infected but asymptomatic subjects. This differential property was stably expressed by the strains even after years of maintenance in stock cultures. Moreover, representative high-proteinase isolates were significantly more pathogenic for mice than low-proteinase isolates of C. albicans. The characters high proteinase and increased virulence were not associated with a single molecular type or category identifiable through DNA fingerprinting or pulsed-field electrophoretic karyotype, and both SAP1 and SAP2 genes were present in both categories of isolates, on the same respective chromosomes. In conclusion, our data suggest that during HIV infection more-virulent strains or biotypes of C. albicans which are identifiable by direct analysis of virulence determinants are selected. It also appears that the biotype switch to increased aspartic proteinase and virulence properties occurs before the HIV-infected subject enters the symptomatic stage and overt AIDS.


This article has been cited by other articles:

  • Challacombe, S.J., Naglik, J.R. (2006). The Effects of HIV Infection on Oral Mucosal Immunity. ADR 19: 29-35 [Abstract] [Full Text]  
  • Menotti, J., Santillana-Hayat, M., Cassinat, B., Sarfati, C., Derouin, F., Molina, J.-M. (2005). Inhibitory Activity of Human Immunodeficiency Virus Aspartyl Protease Inhibitors against Encephalitozoon intestinalis Evaluated by Cell Culture-Quantitative PCR Assay. Antimicrob. Agents Chemother. 49: 2362-2366 [Abstract] [Full Text]  
  • de Repentigny, L., Lewandowski, D., Jolicoeur, P. (2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev. 17: 729-759 [Abstract] [Full Text]  
  • Tavanti, A., Pardini, G., Campa, D., Davini, P., Lupetti, A., Senesi, S. (2004). Differential Expression of Secretory Aspartyl Proteinase Genes (SAP1-10) in Oral Candida albicans Isolates with Distinct Karyotypes. J. Clin. Microbiol. 42: 4726-4734 [Abstract] [Full Text]  
  • Borst, A., Fluit, A. C. (2003). High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. J Med Microbiol 52: 971-974 [Abstract] [Full Text]  
  • Naglik, J. R., Challacombe, S. J., Hube, B. (2003). Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis. Microbiol. Mol. Biol. Rev. 67: 400-428 [Abstract] [Full Text]  
  • Barchiesi, F., Maracci, M., Radi, B., Arzeni, D., Baldassarri, I., Giacometti, A., Scalise, G. (2002). Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. J Antimicrob Chemother 50: 999-1002 [Abstract] [Full Text]  
  • Samaranayake, Y. H., Samaranayake, L. P. (2001). Experimental Oral Candidiasis in Animal Models. Clin. Microbiol. Rev. 14: 398-429 [Abstract] [Full Text]  
  • Vargas, K., Messer, S. A., Pfaller, M., Lockhart, S. R., Stapleton, J. T., Hellstein, J., Soll, D. R. (2000). Elevated Phenotypic Switching and Drug Resistance of Candida albicans from Human Immunodeficiency Virus-Positive Individuals prior to First Thrush Episode. J. Clin. Microbiol. 38: 3595-3607 [Abstract] [Full Text]  
  • O’Day, D. M., Head, W. S., Csank, C., Shetlar, D. J., Robinson, R. D., McCollum, G. W., Yang, R., Zhu, T. L., Wang, M. X. (2000). Differences in Virulence between Two Candida albicans Strains in Experimental Keratitis. IOVS 41: 1116-1121 [Abstract] [Full Text]  
  • Naglik, J. R., Newport, G., White, T. C., Fernandes-Naglik, L. L., Greenspan, J. S., Greenspan, D., Sweet, S. P., Challacombe, S. J., Agabian, N. (1999). In Vivo Analysis of Secreted Aspartyl Proteinase Expression in Human Oral Candidiasis. Infect. Immun. 67: 2482-2490 [Abstract] [Full Text]  
  • de Bernardis, F., Mondello, F., Scaravelli, G., Pachì, A., Girolamo, A., Agatensi, L., Cassone, A. (1999). High Aspartyl Proteinase Production and Vaginitis in Human Immunodeficiency Virus-Infected Women. J. Clin. Microbiol. 37: 1376-1380 [Abstract] [Full Text]  
  • Diz, P., Ocampo, A., Iglesias, I., Otero, I. (1999). Lack of Ritonavir Antifungal Effect In Vitro. Antimicrob. Agents Chemother. 43: 997-997 [Full Text]  
  • Fidel, P. L. Jr., Vazquez, J. A., Sobel, J. D. (1999). Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans. Clin. Microbiol. Rev. 12: 80-96 [Abstract] [Full Text]  
  • Graybill, J. R., Montalbo, E., Kirkpatrick, W. R., Luther, M. F., Revankar, S. G., Patterson, T. F. (1998). Fluconazole versus Candida albicans: A Complex Relationship. Antimicrob. Agents Chemother. 42: 2938-2942 [Abstract] [Full Text]  
  • Chaffin, W. L., Lopez-Ribot, J. L., Casanova, M., Gozalbo, D., Martinez, J. P. (1998). Cell Wall and Secreted Proteins of Candida albicans: Identification, Function, and Expression. Microbiol. Mol. Biol. Rev. 62: 130-180 [Abstract] [Full Text]  
  • Beausejour, A., Grenier, D., Goulet, J.-P., Deslauriers, N. (1998). Proteolytic Activation of the Interleukin-1beta Precursor by Candida albicans. Infect. Immun. 66: 676-681 [Abstract] [Full Text]  
  • Martinez, J. P., Gil, M. L., Lopez-Ribot, J. L., Chaffin, W. L. (1998). Serologic Response to Cell Wall Mannoproteins and Proteins of Candida albicans. Clin. Microbiol. Rev. 11: 121-141 [Abstract] [Full Text]  
  • Newport, G., Agabian, N. (1997). KEX2 Influences Candida albicans Proteinase Secretion and Hyphal Formation. J. Biol. Chem. 272: 28954-28961 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»